Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.29B |
| 2 |
Linde
LIN
|
$1.25B |
| 3 |
Abbott
ABT
|
$931M |
| 4 |
GE Aerospace
GE
|
$868M |
| 5 |
Procter & Gamble
PG
|
$816M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$1.84B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.63B |
| 3 |
JPMorgan Chase
JPM
|
$1.21B |
| 4 |
Meta Platforms (Facebook)
META
|
$1.08B |
| 5 |
Citigroup
C
|
$963M |
Sector Composition
| 1 | Technology | 18.92% |
| 2 | Healthcare | 16.33% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ionis Pharmaceuticals
IONS
$9.76B
| $1.11B | 0.15% |
20,509,750
+45,911
| +0.2% | +$2.48M |
|
127
iShares MSCI EAFE ETF
EFA
$66.2B
| $1.11B | 0.15% |
18,852,846
+8,277,894
| +78% | +$487M |
|
128
Alnylam Pharmaceuticals
ALNY
$59.2B
| $1.1B | 0.15% |
15,154,553
+54,637
| +0.4% | +$3.98M |
|
129
Biogen
BIIB
$20.6B
| $1.1B | 0.15% |
3,671,066
-651,121
| -15% | -$196M |
|
130
Philip Morris
PM
$251B
| $1.1B | 0.15% |
16,473,615
-1,300,505
| -7% | -$86.8M |
|
131
Amdocs
DOX
$9.46B
| $1.07B | 0.15% |
18,209,169
+1,543,698
| +9% | +$90.4M |
|
132
iShares Core S&P 500 ETF
IVV
$664B
| $1.03B | 0.14% |
4,100,274
-2,916,795
| -42% | -$734M |
|
|
CTXS
133
DELISTED
Citrix Systems Inc
CTXS
| $1B | 0.14% |
9,796,045
-399,206
| -4% | -$40.9M |
|
134
BP
BP
$87.4B
| $986M | 0.14% |
26,826,664
+4,619,429
| +21% | +$170M |
|
135
Sherwin-Williams
SHW
$92.9B
| $986M | 0.14% |
7,516,236
-3,231,555
| -30% | -$424M |
|
136
Phillips 66
PSX
$53.2B
| $970M | 0.13% |
11,260,757
-3,099,365
| -22% | -$267M |
|
137
Intel
INTC
$107B
| $967M | 0.13% |
20,607,249
-7,224,979
| -26% | -$339M |
|
138
Accenture
ACN
$159B
| $963M | 0.13% |
6,830,316
+2,217,910
| +48% | +$313M |
|
139
Morgan Stanley
MS
$236B
| $960M | 0.13% |
24,202,184
-8,487,898
| -26% | -$337M |
|
140
Huntington Bancshares
HBAN
$25.7B
| $958M | 0.13% |
80,400,701
-1,383,168
| -2% | -$16.5M |
|
141
Stryker
SYK
$150B
| $930M | 0.13% |
5,934,622
+353,028
| +6% | +$55.3M |
|
142
Neurocrine Biosciences
NBIX
$14.3B
| $930M | 0.13% |
13,016,591
-473,255
| -4% | -$33.8M |
|
|
APC
143
DELISTED
Anadarko Petroleum
APC
| $915M | 0.13% |
20,868,184
+2,251,077
| +12% | +$98.7M |
|
144
Seagate
STX
$40B
| $913M | 0.13% |
23,656,503
+600,068
| +3% | +$23.2M |
|
145
Equinix
EQIX
$75.7B
| $907M | 0.12% |
2,571,552
-54,023
| -2% | -$19M |
|
146
Lam Research
LRCX
$130B
| $906M | 0.12% |
66,525,310
+31,143,930
| +88% | +$424M |
|
147
American International
AIG
$43.9B
| $902M | 0.12% |
22,895,506
-5,410,274
| -19% | -$213M |
|
148
British American Tobacco
BTI
$122B
| $889M | 0.12% |
27,897,707
-4,197,470
| -13% | -$134M |
|
149
Gilead Sciences
GILD
$143B
| $884M | 0.12% |
14,131,228
-4,079,394
| -22% | -$255M |
|
150
ResMed
RMD
$40.6B
| $871M | 0.12% |
7,644,715
-224,877
| -3% | -$25.6M |
|